The cutting edge of chemistry
Our new free report in the Pharma Matters series delivers a quarterly review of the latest chemistry shaping today's drug discovery and development pipeline.
Chemistry is one of the key drivers of drug discovery and innovation - making it more important than ever to keep up with the latest chemistry news.
The Cutting Edge of Chemistry, our newest FREE report in the Pharma Matters series, draws on expert insight and strategic data from Prous Science Integrity®—a unique database integrating biological, chemical and pharmacological data. The Cutting Edge of Chemistry helps you stay on the leading edge of chemistry innovation.
In this first issue:
- New organic synthesis schemes: keep in touch with advances in synthesis techniques, this issue includes intriguing new syntheses for two osteoporosis drugs from GlaxoSmithKline and Merck & Co
- The newest molecules: highlighting new molecular entities of interest.
- Chemical scaffolds: illustrating newly synthesized or natural product-derived templates laying the groundwork for discovery of new therapeutic agents
- Insights into new mechanisms of action: leading to oncolytic drug development.
Subscribe now at http://science.thomsonreuters.com/info/matters/
Prous Science Integrity is populated, refined, and supported by PhD scientists to meet the specific needs of drug discovery chemists. It connects biological, chemical and pharmacological data, to help chemists make confident decisions, keep research focused, and foster innovation.
Additional information
Was this article useful?
Register now to receive KnowledgeLink direct to your mailbox every two months.
Download a PDF of all
February 2010's
KnowledgeLink articles